Analysis of comprehensive biomarker profiles of Mexico City Prospective Study blood samples may provide insight into the ethnic and socioeconomic differences that underlie disease risk.
Read More
Published findings show initial testing for three specific biomarkers may provide superior results over standard screening methods.
Read More
The test from 23andMe is the first to report on three specific BRCA1/BRCA2 breast cancer gene mutations that are most common in people of Ashkenazi Jewish descent.
Read More
With tens of thousands of flu cases, more than 10,000 reported hospitalizations, and scores of deaths—including more than 60 young children—this flu season is the worst in a decade and one of the worst on record.
Read More
At the 2017 San Antonio Breast Cancer Symposium, Agendia presented extensive new data highlighting the value of its MammaPrint 70-gene breast cancer risk-of-recurrence test and BluePrint breast cancer molecular subtyping test.
Read More